Get the Stockscreener App
1.96
4.66%
-0.08
Mainz Biomed N V stock is traded at $1.96, with a volume of 71,294.
It is down -4.66% in the last 24 hours and up +40.94% over the past month.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
See More
Previous Close:
$2.04
Open:
$2.07
24h Volume:
71,294
Relative Volume:
0.37
Market Cap:
$6.74M
Revenue:
$895.50K
Net Income/Loss:
$-26.30M
P/E Ratio:
-1.1951
EPS:
-1.64
Net Cash Flow:
$-23.84M
1W Performance:
-8.69%
1M Performance:
+40.94%
6M Performance:
-62.45%
1Y Performance:
-85.52%
1-Day Range:
$1.93
$2.07
1-Week Range:
$1.8926
$2.15
52-Week Range:
$1.3381
$19.00
Mainz Biomed N V Stock (MYNZ) Company Profile
Name
Mainz Biomed N V
Sector
Industry
Phone
-
Address
-
Compare MYNZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.96 | 7.78M | 895.50K | -26.30M | -23.84M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
485.69 | 180.56B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
202.89 | 147.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
566.86 | 45.45B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.58 | 34.14B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
198.04 | 33.86B | 15.50B | 1.33B | 2.16B | 7.34 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Maxim Group | Buy |
| Nov-25-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-21-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-21-22 | Initiated | H.C. Wainwright | Buy |
Mainz Biomed N V Stock (MYNZ) Latest News
What institutional investors are buying Mainz Biomed N.V. stockTop Growth Opportunities For Fast Growth - jammulinksnews.com
How does Mainz Biomed N.V. compare to its industry peersExplosive wealth accumulation - jammulinksnews.com
What is the risk reward ratio of investing in Mainz Biomed N.V. stockCapitalize on market trends with expert guidance - jammulinksnews.com
What catalysts could drive Mainz Biomed N.V. stock higher in 2025Achieve superior returns through strategic trading - jammulinksnews.com
Why Mainz Biomed N.V. stock attracts strong analyst attentionHigh Return Investment Tips - Metal.it
What is the dividend policy of Mainz Biomed N.V. stockBuild wealth steadily with smart trading - jammulinksnews.com
How strong is Mainz Biomed N.V. company’s balance sheetFree Stock Market Return Analysis - jammulinksnews.com
Why is Mainz Biomed N.V. stock attracting strong analyst attentionHigh-yield trading alerts - jammulinksnews.com
What institutions are buying Mainz Biomed N.V. stock nowFree Stock Market Swing Trading Strategies - Metal.it
Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - jammulinksnews.com
Does Mainz Biomed N.V. stock pay reliable dividendsRapid capital growth - jammulinksnews.com
Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - jammulinksnews.com
What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional
Mainz Biomed, CARE announce collaboration agreement - TipRanks
Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany - Nasdaq
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire
Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan
When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com
What analysts say about Mainz Biomed N.V. stockConsistently profitable trades - jammulinksnews.com
Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com
Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World
Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire
What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser
ARBI(arbipad) News and UpdatesProtected Capital Trading Plan - Newser
Mainz Biomed N V Stock (MYNZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):